Reaching a fifteen-year milestone means much more than simply commemorating a date – it’s about celebrating a path marked by commitment, resilience, and collective achievement. As Berlin-Chemie Menarini’s Kyrgyzstan branch marked this important anniversary in 2024, there’s plenty to be proud of: years of meaningful contributions and steady growth representing the Menarini Group in the region.

Over the years, Berlin-Chemie Menarini has built a solid foothold in Kyrgyzstan’s pharmaceutical landscape, becoming a trusted and well-known name. The company has consistently expanded its regional influence thanks to its commitment to quality products and the efforts of its team – over twenty dedicated professionals who bring their expertise to work every day.

Every day, these professionals work with a shared commitment to upholding the Menarini Group’s values and standards of excellence, ensuring patients have access to effective and reliable therapeutic solutions.

The company’s product portfolio includes treatments for a variety of conditions, such as cardiovascular diseases, diabetes, thyroid disorders, inflammatory conditions, gastrointestinal issues, hypertension, and allergies. The core of its business remains prescription medications, which make up the majority of its revenue.

Education stands at the heart of Berlin-Chemie Menarini’s philosophy. The company consistently supports medical and scientific learning through carefully organized educational programs and professional development opportunities. Two standout initiatives – the Berlin-Chemie Menarini Cardio School and Thyroid School – have gained recognition as premier educational platforms. These programs bring together renowned specialists from around the world and serve as vital knowledge hubs for heart specialists, hormone experts, and family doctors across the region.

Meanwhile, the company is making strategic moves into the Consumer Healthcare space. Over-the-counter (OTC) products are becoming an increasingly important segment of the market, now accounting for approximately one-third of total sales. This shift reflects a growing consumer preference for trusted and high-quality self-care solutions.

Berlin-Chemie Menarini’s success is built on two key factors: a highly motivated and cohesive team and a clear, forward-looking strategy that is closely aligned with the broader regional approach of Berlin-Chemie Menarini CEE & CIS.

Standing on this solid ground, the company looks ahead with confidence, ready to grow its market share while continuing to bring meaningful healthcare innovations to patients throughout Kyrgyzstan.